What's Happening?
Stealth BioTherapeutics, a biotechnology company focused on developing therapies for mitochondrial dysfunction, has received a grant from the UK Research and Innovation Medical Research Council's (MRC) Business Engagement Fund. This grant will support
a collaborative research project aimed at evaluating the effects of SBT-589, a lead compound in the company's pipeline, on Leigh syndrome. The research will be conducted in partnership with the Mary Lyon Centre at MRC Harwell, the MRC National Mouse Genetics Network, and University College London. The project will focus on assessing survival rates, motor function, and disease biomarkers in a mouse model of Leigh syndrome, a condition characterized by mitochondrial dysfunction affecting energy supply to the brain, nerves, and muscles.
Why It's Important?
The grant and subsequent research are significant as they aim to address the unmet needs of individuals suffering from mitochondrial dysfunction diseases, such as Leigh syndrome. By fostering collaboration between industry and academia, the project seeks to accelerate the development of promising mitochondrial therapies towards clinical application. This initiative could potentially lead to breakthroughs in treating mitochondrial diseases, which currently have limited therapeutic options. The success of this research could pave the way for new treatments, improving the quality of life for patients and advancing scientific understanding of mitochondrial dysfunction.
What's Next?
The research collaboration will proceed with preclinical evaluations of SBT-589, leveraging the expertise and resources of the MRC National Mouse Genetics Network. The outcomes of these studies could lead to further clinical trials and regulatory milestones, potentially bringing new therapies to market. The collaboration aims to overcome historical barriers in mitochondrial drug development by testing promising compounds in disease-relevant models, thereby enhancing the translation of scientific discoveries into clinical applications.
